Merck & Co., Inc. Restarts Cholesterol Race Four Years After Pfizer Inc. Failure

Bloomberg -- Merck & Co. is betting it can succeed where Pfizer Inc. failed, with a new type of drug to combat heart disease by raising good cholesterol levels.
MORE ON THIS TOPIC